RxSight, Inc. RXST Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$46.64M-19.8% | -$38.94M-9.0% | -$35.73M-10.8% | -$32.25M-21.5% | -$26.55M+3.3% | ||
| $3.32M+1.8% | $3.27M+11.5% | $2.93M-8.7% | $3.21M-0.8% | $3.24M-9.5% | ||
| $32.42M+2.5% | $31.61M+1.7% | $31.08M+5.3% | $29.52M+9.0% | $27.08M+9.9% | ||
| -$8.52M-28.0% | -$6.66M-462% | -$1.19M-144% | $2.72M-72.2% | $9.78M-3.4% | ||
| $13.26M+15.4% | $11.48M+32.5% | $8.67M+21.9% | $7.11M+36.7% | $5.2M+4.1% | ||
| -$22K-104% | $627K+143% | -$1.46M-9.5% | -$1.33M— | —— | ||
| —— | —— | —— | —— | $3.44M-41.3% | ||
| —— | —— | -$33K-129% | $112K-92.5% | $1.5M+26.7% | ||
| —— | —— | $8K-50.0% | $16K-51.5% | $33K-32.7% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$17.57M-13.3% | -$15.51M+16.9% | -$18.66M-6.8% | -$17.47M-2.0% | -$17.12M+2.7% | ||
| $4.01M+4.8% | $3.83M+8.2% | $3.54M-12.9% | $4.06M+0.3% | $4.05M-25.6% | ||
| $301.1M+25.8% | $239.28M+23.6% | $193.64M-4.3% | $202.37M-38.2% | $327.68M-2.7% | ||
| $310M+19.2% | $260M+15.6% | $225M-3.8% | $234M+2.2% | $229M-5.8% | ||
| —— | —— | —— | $26.25M+125% | -$104.05M-3.4% | ||
| $3.4M-14.0% | $3.95M-32.8% | $5.88M-38.6% | $9.59M-15.6% | $11.36M-45.4% | ||
| —— | —— | $47K+20.5% | $39K-17.0% | $47K-23.0% | ||
| —— | $0— | $0+100% | -$80K— | —— | ||
| —— | —— | —— | $5.18M-95.5% | $114.59M-7.1% | ||
| —— | —— | —— | $15K— | $0+100% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $72K+148% | $29K+11.5% | ||
| $7.96M-6.5% | $8.52M-8.5% | $9.31M-6.3% | $9.94M+0.6% | $9.88M+10.1% | ||
| —— | —— | —— | —— | $3.44M-41.3% | ||
| —— | —— | -$33K-129% | $112K-92.5% | $1.5M+26.7% | ||
| $1.96M+1.5% | $1.93M+39.3% | $1.39M-6.7% | $1.49M+359% | $324K-19.8% | ||
| —— | —— | $8K-50.0% | $16K-51.5% | $33K-32.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $66K+20.0% | $55K+61.8% | ||
| $301.1M+25.8% | $239.28M+23.6% | $193.64M-4.3% | $202.37M-38.2% | $327.68M-2.7% | ||
| $310M+19.2% | $260M+15.6% | $225M-3.8% | $234M+2.2% | $229M-5.8% | ||
| —— | —— | $47K+20.5% | $39K-17.0% | $47K-23.0% | ||
| -$1.12M+45.8% | -$2.06M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $566K— | —— | ||
| $2.91M+10.9% | $2.63M+6.6% | $2.46M+2.3% | $2.41M+4.7% | $2.3M+6.8% | ||
| —— | $0— | $0— | $0— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $72K+148% | $29K+11.5% | ||
| -$21.58M-11.6% | -$19.34M+12.9% | -$22.2M-6.3% | -$20.88M-1.8% | -$20.52M+8.3% | ||
| -$21.58M-11.6% | -$19.34M+12.9% | -$22.2M-6.3% | -$20.88M-1.8% | -$20.52M+8.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does RxSight, Inc. generate?
- RxSight, Inc. (RXST) generated -$17.6M in operating cash flow over the trailing twelve months.
- What is RxSight, Inc.'s free cash flow?
- After $4.0M of capital expenditures, RxSight, Inc.'s free cash flow was -$21.6M over the trailing twelve months, down 5.2% year over year.
- Where does RxSight, Inc.'s cash flow data come from?
- Every line is extracted from RxSight, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
